Cue Biopharma (CUE) Revenue (2018 - 2026)

Cue Biopharma has disclosed Revenue across 9 years of filings, most recently posting $7.9 million for Q2 2026.

• In Q2 2026, Revenue rose 166.66% year-over-year to $7.9 million; the TTM figure through Jun 2026 stood at $22.5 million (up 171.27% YoY), while the FY2025 annual figure was $27.5 million, up 195.75% from the prior year.
• Revenue came in at $7.9 million for Q2 2026 at Cue Biopharma, down from $9.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $9.5 million in Q4 2025 to a low of $26000.0 in Q2 2022.
• Average Revenue over 5 years is $2.3 million, with a median of $1.7 million recorded in 2024.
• Year-over-year, Revenue plunged 99.05% in 2022 and soared 5215.38% in 2023.
• Over 5 years, Revenue stood at $151000.0 in 2022, then surged by 1105.96% to $1.8 million in 2023, then dropped by 13.45% to $1.6 million in 2024, then surged by 502.79% to $9.5 million in 2025, then declined by 17.08% to $7.9 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $7.9 million in Q2 2026, $9.5 million in Q4 2025, and $2.1 million in Q3 2025.